Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lite Strategy, Inc.LITS · Entity 7396 | Director | November 14, 2025 | November 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lite Strategy, Inc.
Report date November 14, 2025 · Filed November 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.02 · Expires 2035-11-14 | Direct | 55,000 |
Reported balance
After 2025-11-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-14 · Grant · Acquired 55,000 · Balance 55,000 F2: Received as compensation for service on the Board. F1: Customary annual grant to non-employee directors of options to purchase shares of common stock. Such options shall vest as follows: 16.66666% shall be vested on the date of grant, and the remaining shares subject to the option shall vest in monthly amounts beginning December 14, 2025 and continuing on the first day of each calendar month following such date and continuing through November 14, 2026. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.02 · Expires 2035-11-14 | Direct | 10,000 |
Reported balance
After 2025-11-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-11-14 · Grant · Acquired 10,000 · Balance 10,000 F2: Received as compensation for service on the Board. F3: Customary grant upon appointment of non-employee directors to our Board as revised on November 14, 2025, less options to purchase shares of common stock previously made to Mr. Riezman on August 8, 2025. Such options shall vest and become exercisable in 36 monthly installments, with the first installment vesting on the one-month anniversary of the date of grant, subject to continued service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Customary annual grant to non-employee directors of options to purchase shares of common stock. Such options shall vest as follows: 16.66666% shall be vested on the date of grant, and the remaining shares subject to the option shall vest in monthly amounts beginning December 14, 2025 and continuing on the first day of each calendar month following such date and continuing through November 14, 2026.
F2: Received as compensation for service on the Board.
F3: Customary grant upon appointment of non-employee directors to our Board as revised on November 14, 2025, less options to purchase shares of common stock previously made to Mr. Riezman on August 8, 2025. Such options shall vest and become exercisable in 36 monthly installments, with the first installment vesting on the one-month anniversary of the date of grant, subject to continued service through the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 14, 2025 Filed Nov 18, 2025 17:09 UTC | Lite Strategy, Inc. LITS · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 10,000 | Not disclosed Strike: $2.02 | Not disclosed |
DisclosureSEC source: 0001193125-25-286429 · ownership.xml · derivative · entry 2 Riezman Joshua · CIK 0002082518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2035-11-14 F2 · price: Received as compensation for service on the Board. F3 · derivative.exercise_date: Customary grant upon appointment of non-employee directors to our Board as revised on November 14, 2025, less options to purchase shares of common stock previously made to Mr. Riezman on August 8, 2025. Such options shall vest and become exercisable in 36 monthly installments, with the first installment vesting on the one-month anniversary of the date of grant, subject to continued service through the applicable vesting date. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 17:09 UTC | Lite Strategy, Inc. LITS · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 55,000 | Not disclosed Strike: $2.02 | Not disclosed |
DisclosureSEC source: 0001193125-25-286429 · ownership.xml · derivative · entry 1 Riezman Joshua · CIK 0002082518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2035-11-14 F2 · price: Received as compensation for service on the Board. F1 · derivative.exercise_date: Customary annual grant to non-employee directors of options to purchase shares of common stock. Such options shall vest as follows: 16.66666% shall be vested on the date of grant, and the remaining shares subject to the option shall vest in monthly amounts beginning December 14, 2025 and continuing on the first day of each calendar month following such date and continuing through November 14, 2026. Read SEC document |
| August 08, 2025 Filed Aug 20, 2025 17:56 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $5.19 | $0.00 |
DisclosureSEC source: 0000929638-25-003120 · form4.xml · derivative · entry 1 Riezman Joshua · CIK 0002082518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2035-08-08 F1 · derivative.exercise_date: Such option shall vest and become exercisable in 36 equal monthly installments, with the first installment vesting on the one-month anniversary of the date of grant, subject to continued service through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.